BridgeMD
Tests treatment safety and results for Acute Herpes Zoster
Official title Efficacy of Electroacupuncture for Acute Herpes Zoster-Associated Pain and Biomarker Evaluation
ClinicalTrials.gov ID: NCT07515885
What this study is testing
What is Valacyclovir, pregabalin and mecobalamin?
Valacyclovir, pregabalin and mecobalamin is an investigational medicine, given as an once-daily pill taken by mouth, being studied as a potential treatment for acute herpes zoster.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- Background: Herpes zoster (HZ) is an acute dermatological condition caused by the varicella-zoster virus. Its onset is characterized by severe pain, imposing significant physical and psychological burdens on patients.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 20 to 80
You may be able to join if
- Patients who meet the diagnostic criteria for acute HZ27 and skin symptom appears less than 7 days;
- Only have lesions in the trunk and limbs; 2\. Patients with a Numerical Rating Scale (NRS) score ≥ 4; 3. Aged between 20 and 80 years; 4. Patients...
You likely can't join if
- Special types of HZ that occur in head, eyes, viscera, etc. or those combined with other skin diseases;
- Has received relevant treatment and it may affect the observation indicators;
- Pregnant and lactating women;
- Patients who are allergic to iodophor or other topical disinfectants, or a history of sudden, potentially life-threatening systemic allergic...
- Those who are afraid of acupuncture or have metal implants and are not suitable for EA treatment;
- Those with contraindications to pregabalin such as congestive heart disease and heart failure;
See the full eligibility criteria
- Patients who meet the diagnostic criteria for acute HZ27 and skin symptom appears less than 7 days;
- Only have lesions in the trunk and limbs; 2\. Patients with a Numerical Rating Scale (NRS) score ≥ 4; 3. Aged between 20 and 80 years; 4. Patients voluntarily participate in the trial and are willing to sign the...
- Special types of HZ that occur in head, eyes, viscera, etc. or those combined with other skin diseases;
- Has received relevant treatment and it may affect the observation indicators;
- Pregnant and lactating women;
- Patients who are allergic to iodophor or other topical disinfectants, or a history of sudden, potentially life-threatening systemic allergic reactions;
- Those who are afraid of acupuncture or have metal implants and are not suitable for EA treatment;
- Those with contraindications to pregabalin such as congestive heart disease and heart failure;
- Patients with severe primary diseases such as liver, kidney, cardiovascular and cerebrovascular, metabolic, autoimmune system diseases, malignant tumors, etc., and those with mental illness;
- Patients who have hematologic diseases or coagulation disorders;
- Patients who are currently participating in other clinical studies.
The study team makes the final eligibility decision.
Where it's taking place
- Hangzhou, Zhejiang, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 20 years to 80 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Hangzhou, Zhejiang, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.